Walleye Trading
ARNA

Walleye Trading’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Walleye Trading’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-28,600
Closed -$2.66M – 6178
2021
Q4 		$2.66M Sell
28,600
-29,500
-51% -$1.94M 0.01% 1401
2021
Q3 		$3.46M Buy
58,100
+45,700
+369% +$2.7M 0.01% 1153
2021
Q2 		$846K Buy
12,400
+600
+5% +$39.1K ﹤0.01% 2312
2021
Q1 		$819K Buy
11,800
+3,500
+42% +$269K ﹤0.01% 2107
2020
Q4 		$638K Buy
8,300
+3,000
+57% +$225K ﹤0.01% 2438
2020
Q3 		$396K Buy
+5,300
New +$353K ﹤0.01% 2451
2020
Q1 		– Sell
-1,900
Closed -$86K – 4787
2019
Q4 		$86K Sell
1,900
-4,600
-71% -$217K ﹤0.01% 3624
2019
Q3 		$298K Buy
6,500
+4,100
+171% +$230K ﹤0.01% 2589
2019
Q2 		$141K Sell
2,400
-3,900
-62% -$202K ﹤0.01% 3158
2019
Q1 		$282K Buy
6,300
+5,300
+530% +$243K ﹤0.01% 2745
2018
Q4 		$39K Buy
+1,000
New +$39.3K ﹤0.01% 4214

Walleye Trading's ARNA Position: Q2 2021 in Review

Walleye Trading sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2021, closing a stake of 14,862 shares — an estimated $969K sold.

Walleye Trading first reported a position in ARNA in Q2 2015 and held it in 6 quarters. The position peaked at $1.03M in Q1 2021. 237 funds tracked by Wall St. Rank hold ARNA as of Q2 2021.

  • Walleye Trading reported no remaining Arena Pharmaceuticals Inc position as of Q2 2021 after selling out during the quarter.
  • Walleye Trading sold 14,862 Arena Pharmaceuticals Inc shares in Q2 2021, an estimated $969K.
  • Walleye Trading first reported a position in Arena Pharmaceuticals Inc in Q2 2015 and held it in 6 quarters.
  • Walleye Trading's Arena Pharmaceuticals Inc position peaked at $1.03M in Q1 2021.
  • 237 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2021.

Based on Walleye Trading's 13F filing for Q2 2021, filed 16 Aug 2021.